International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.

Combination Chemotherapy for Metastatic Hepatic Carcinoma and the Relation of Immune Status to the Response

Author(s) Dharmendra Singh, Sakshi Sharma, Sandeep Bairwa
Country India
Abstract Metastatic carcinoma presents a significant challenge in cancer treatment due to its aggressive nature and propensity for resistance to traditional therapeutic approaches. This systematic research paper delves into the development and evaluation of a novel combination chemotherapy regimen involving the use of 5-fluorouracil, cyclophosphamide & mitomycin C, and PHA skin test in the treatment of metastatic carcinoma, lymphomas, and breast cancer. The study aims to investigate the efficacy and safety profile of this combined chemotherapeutic approach, utilizing scientific methodology and analysis to assess its potential as a promising treatment option for patients with advanced cancer.
Keywords Metastatic Hepatic carcinoma, Combination chemotherapy, 5-fluorouracil, cyclophosphamide, mitomycin C, PHA skin test, therapeutic efficacy, personalized medicine, preclinical models, clinical trials.
Field Medical / Pharmacy
Published In Volume 6, Issue 4, July-August 2024
Published On 2024-07-30
Cite This Combination Chemotherapy for Metastatic Hepatic Carcinoma and the Relation of Immune Status to the Response - Dharmendra Singh, Sakshi Sharma, Sandeep Bairwa - IJFMR Volume 6, Issue 4, July-August 2024. DOI 10.36948/ijfmr.2024.v06i04.25447
DOI https://doi.org/10.36948/ijfmr.2024.v06i04.25447
Short DOI https://doi.org/gt553t

Share this